RCM
GWPH

Riverhead Capital Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Riverhead Capital Management’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$12K Hold
107
– – ﹤0.01% 1485
2019
Q2 		$19K Sell
107
-8
-7% -$1.38K ﹤0.01% 1497
2019
Q1 		$19K Buy
+115
New +$17.1K ﹤0.01% 1473

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Riverhead Capital Management's GWPH Position: Q3 2019 in Review

Riverhead Capital Management held its GW Pharmaceuticals Plc American Depositary Shares (GWPH) position steady in Q3 2019 at 107 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #1485.

Riverhead Capital Management first reported a position in GWPH in Q1 2019 and has held it in 3 quarters since. The position peaked at $19K in Q2 2019. 316 funds tracked by Wall St. Rank hold GWPH as of Q3 2019.

  • Riverhead Capital Management held 107 shares of GW Pharmaceuticals Plc American Depositary Shares worth $12K as of Q3 2019.
  • Riverhead Capital Management left its GW Pharmaceuticals Plc American Depositary Shares share count unchanged in Q3 2019.
  • GW Pharmaceuticals Plc American Depositary Shares made up ﹤0.01% of Riverhead Capital Management's portfolio in Q3 2019, its #1485 holding.
  • Riverhead Capital Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2019 and has held it in 3 quarters since.
  • Riverhead Capital Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $19K in Q2 2019.
  • 316 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.